מעכבי 5-אלפא רדוקטאז (Hebrew Wikipedia)

Analysis of information sources in references of the Wikipedia article "מעכבי 5-אלפא רדוקטאז" in Hebrew language version.

refsWebsite

Global rank Hebrew rank

13nih.gov

4^th place

18^th place

10doi.org

2^nd place

10^th place

4books.google.com

3^rd place

33^rd place

4semanticscholar.org

11^th place

383^rd place

2worldcat.org

5^th place

31^st place

1springer.com

274^th place

120^th place

1in-pharmatechnologist.com

low place

1drugs.com

399^th place

650^th place

books.google.com

Ulrike Blume-Peytavi; David A. Whiting; Ralph M. Trüeb (26 ביוני 2008). Hair Growth and Disorders. Springer Science & Business Media. pp. 368–370. ISBN 978-3-540-46911-7. {{cite book}}: (עזרה)
Alfred Burger; Donald J. Abraham (20 בפברואר 2003). Burger's Medicinal Chemistry and Drug Discovery, Autocoids, Diagnostics, and Drugs from New Biology. Wiley. p. 439. ISBN 978-0-471-37030-7. {{cite book}}: (עזרה)
William Llewellyn (2011). Anabolics. Molecular Nutrition Llc. pp. 968–, 971–. ISBN 978-0-9828280-1-4.
Robert T Sataloff; Anthony P Sclafani (30 בנובמבר 2015). Sataloff's Comprehensive Textbook of Otolaryngology: Head & Neck Surgery: Facial Plastic and Reconstructive Surgery. JP Medical Ltd. pp. 400–. ISBN 978-93-5152-459-5. {{cite book}}: (עזרה)

doi.org

Wesp LM, Deutsch MB (2017). "Hormonal and Surgical Treatment Options for Transgender Women and Transfeminine Spectrum Persons". Psychiatr. Clin. North Am. 40 (1): 99–111. doi:10.1016/j.psc.2016.10.006. PMID 28159148.
Trost L, Saitz TR, Hellstrom WJ (2013). "Side Effects of 5-Alpha Reductase Inhibitors: A Comprehensive Review". Sex Med Rev. 1 (1): 24–41. doi:10.1002/smrj.3. PMID 27784557.
Welk B, McArthur E, Ordon M, Anderson KK, Hayward J, Dixon S (2017). "Association of Suicidality and Depression With 5α-Reductase Inhibitors". JAMA Intern Med. 177 (5): 683–691. doi:10.1001/jamainternmed.2017.0089. PMC 5818776. PMID 28319231.
Welk, Blayne; McArthur, Eric; Ordon, Michael; Morrow, Sarah A.; Hayward, Jade; Dixon, Stephanie (2017). "The risk of dementia with the use of 5 alpha reductase inhibitors". Journal of the Neurological Sciences. 379: 109–111. doi:10.1016/j.jns.2017.05.064. ISSN 0022-510X. PMID 28716218. S2CID 4765640.
Yamana K, Labrie F, Luu-The V (בינואר 2010). "Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride". Hormone Molecular Biology and Clinical Investigation. 2 (3): 293–9. doi:10.1515/hmbci.2010.035. PMID 25961201. S2CID 28841145. {{cite journal}}: (עזרה)
Yamana K.; Labrie F.; Luu-The V.; et al. (2010). "Human type 3 5α- reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited finasteride and dutasteride". Hormone Molecular Biology and Clinical Investigation. 2 (3): 293–299. doi:10.1515/hmbci.2010.035. PMID 25961201. S2CID 28841145.
McConnell J. D.; Wilson J. D.; George F. W.; Geller J.; Pappas F.; Stoner E. (1992). "Finasteride, an inhibitor of 5α-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia". Journal of Clinical Endocrinology and Metabolism. 74 (3): 505–508. doi:10.1210/jc.74.3.505. PMID 1371291.
Clark R. V.; Hermann D. J.; Cunningham G. R.; Wilson T. H.; Morrill B. B.; Hobbs S. (2004). "Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor". Journal of Clinical Endocrinology and Metabolism. 89 (5): 2179–2184. doi:10.1210/jc.2003-030330. PMID 15126539.
Moss G. P. (1989). "Nomenclature of steroids (Recommendations 1989)". Pure and Applied Chemistry. 61 (10): 1783–1822. doi:10.1351/pac198961101783. S2CID 97612891.
Thompson, Ian M. Jr.; Goodman, Phyllis J.; Tangen, Catherine M.; Parnes, Howard L.; Minasian, Lori M.; Godley, Paul A.; Lucia, M. Scott; Ford, Leslie G. (2013-08-15). "Long-Term Survival of Participants in the Prostate Cancer Prevention Trial". New England Journal of Medicine. 369 (7): 603–610. doi:10.1056/NEJMoa1215932. ISSN 0028-4793. PMC 4141537. PMID 23944298.

drugs.com

"Generic Avodart Availability".

in-pharmatechnologist.com

MacDonald, Gareth. "GSK Japan delays alopecia drug launch after Catalent manufacturing halt".

nih.gov

pubmed.ncbi.nlm.nih.gov

Wesp LM, Deutsch MB (2017). "Hormonal and Surgical Treatment Options for Transgender Women and Transfeminine Spectrum Persons". Psychiatr. Clin. North Am. 40 (1): 99–111. doi:10.1016/j.psc.2016.10.006. PMID 28159148.
Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS (2016). "Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review". J Clin Aesthet Dermatol. 9 (7): 56–62. PMC 5023004. PMID 27672412.
Trost L, Saitz TR, Hellstrom WJ (2013). "Side Effects of 5-Alpha Reductase Inhibitors: A Comprehensive Review". Sex Med Rev. 1 (1): 24–41. doi:10.1002/smrj.3. PMID 27784557.
Welk B, McArthur E, Ordon M, Anderson KK, Hayward J, Dixon S (2017). "Association of Suicidality and Depression With 5α-Reductase Inhibitors". JAMA Intern Med. 177 (5): 683–691. doi:10.1001/jamainternmed.2017.0089. PMC 5818776. PMID 28319231.
Welk, Blayne; McArthur, Eric; Ordon, Michael; Morrow, Sarah A.; Hayward, Jade; Dixon, Stephanie (2017). "The risk of dementia with the use of 5 alpha reductase inhibitors". Journal of the Neurological Sciences. 379: 109–111. doi:10.1016/j.jns.2017.05.064. ISSN 0022-510X. PMID 28716218. S2CID 4765640.
Yamana K, Labrie F, Luu-The V (בינואר 2010). "Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride". Hormone Molecular Biology and Clinical Investigation. 2 (3): 293–9. doi:10.1515/hmbci.2010.035. PMID 25961201. S2CID 28841145. {{cite journal}}: (עזרה)
Yamana K.; Labrie F.; Luu-The V.; et al. (2010). "Human type 3 5α- reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited finasteride and dutasteride". Hormone Molecular Biology and Clinical Investigation. 2 (3): 293–299. doi:10.1515/hmbci.2010.035. PMID 25961201. S2CID 28841145.
McConnell J. D.; Wilson J. D.; George F. W.; Geller J.; Pappas F.; Stoner E. (1992). "Finasteride, an inhibitor of 5α-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia". Journal of Clinical Endocrinology and Metabolism. 74 (3): 505–508. doi:10.1210/jc.74.3.505. PMID 1371291.
Clark R. V.; Hermann D. J.; Cunningham G. R.; Wilson T. H.; Morrill B. B.; Hobbs S. (2004). "Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor". Journal of Clinical Endocrinology and Metabolism. 89 (5): 2179–2184. doi:10.1210/jc.2003-030330. PMID 15126539.
Thompson, Ian M. Jr.; Goodman, Phyllis J.; Tangen, Catherine M.; Parnes, Howard L.; Minasian, Lori M.; Godley, Paul A.; Lucia, M. Scott; Ford, Leslie G. (2013-08-15). "Long-Term Survival of Participants in the Prostate Cancer Prevention Trial". New England Journal of Medicine. 369 (7): 603–610. doi:10.1056/NEJMoa1215932. ISSN 0028-4793. PMC 4141537. PMID 23944298.

ncbi.nlm.nih.gov

Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS (2016). "Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review". J Clin Aesthet Dermatol. 9 (7): 56–62. PMC 5023004. PMID 27672412.
Welk B, McArthur E, Ordon M, Anderson KK, Hayward J, Dixon S (2017). "Association of Suicidality and Depression With 5α-Reductase Inhibitors". JAMA Intern Med. 177 (5): 683–691. doi:10.1001/jamainternmed.2017.0089. PMC 5818776. PMID 28319231.
Thompson, Ian M. Jr.; Goodman, Phyllis J.; Tangen, Catherine M.; Parnes, Howard L.; Minasian, Lori M.; Godley, Paul A.; Lucia, M. Scott; Ford, Leslie G. (2013-08-15). "Long-Term Survival of Participants in the Prostate Cancer Prevention Trial". New England Journal of Medicine. 369 (7): 603–610. doi:10.1056/NEJMoa1215932. ISSN 0028-4793. PMC 4141537. PMID 23944298.

semanticscholar.org

api.semanticscholar.org

Welk, Blayne; McArthur, Eric; Ordon, Michael; Morrow, Sarah A.; Hayward, Jade; Dixon, Stephanie (2017). "The risk of dementia with the use of 5 alpha reductase inhibitors". Journal of the Neurological Sciences. 379: 109–111. doi:10.1016/j.jns.2017.05.064. ISSN 0022-510X. PMID 28716218. S2CID 4765640.
Yamana K, Labrie F, Luu-The V (בינואר 2010). "Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride". Hormone Molecular Biology and Clinical Investigation. 2 (3): 293–9. doi:10.1515/hmbci.2010.035. PMID 25961201. S2CID 28841145. {{cite journal}}: (עזרה)
Yamana K.; Labrie F.; Luu-The V.; et al. (2010). "Human type 3 5α- reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited finasteride and dutasteride". Hormone Molecular Biology and Clinical Investigation. 2 (3): 293–299. doi:10.1515/hmbci.2010.035. PMID 25961201. S2CID 28841145.
Moss G. P. (1989). "Nomenclature of steroids (Recommendations 1989)". Pure and Applied Chemistry. 61 (10): 1783–1822. doi:10.1351/pac198961101783. S2CID 97612891.

springer.com

adisinsight.springer.com

"Epristeride - AdisInsight".

worldcat.org

Welk, Blayne; McArthur, Eric; Ordon, Michael; Morrow, Sarah A.; Hayward, Jade; Dixon, Stephanie (2017). "The risk of dementia with the use of 5 alpha reductase inhibitors". Journal of the Neurological Sciences. 379: 109–111. doi:10.1016/j.jns.2017.05.064. ISSN 0022-510X. PMID 28716218. S2CID 4765640.
Thompson, Ian M. Jr.; Goodman, Phyllis J.; Tangen, Catherine M.; Parnes, Howard L.; Minasian, Lori M.; Godley, Paul A.; Lucia, M. Scott; Ford, Leslie G. (2013-08-15). "Long-Term Survival of Participants in the Prostate Cancer Prevention Trial". New England Journal of Medicine. 369 (7): 603–610. doi:10.1056/NEJMoa1215932. ISSN 0028-4793. PMC 4141537. PMID 23944298.